Cosmos Health Temettü

Temettü kriter kontrolleri 0/6

Cosmos Health şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

-68.0%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-68.0%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Positive Sentiment Still Eludes Cosmos Health Inc. (NASDAQ:COSM) Following 26% Share Price Slump

Aug 16

Slammed 27% Cosmos Health Inc. (NASDAQ:COSM) Screens Well Here But There Might Be A Catch

Feb 23

Cosmos climbs 11% on Cana Laboratories acquisition, expanding product line and integrating vertically

Jul 20

Cosmos Holdings to acquire bone health product portfolio from LIFE NLB

Jul 06

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: COSM şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: COSM şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Cosmos Health Piyasaya Karşı Temettü Getirisi

COSM temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (COSM)	n/a
Pazarın Alt %25'i (US)	1.5%
Pazarın En İyi %25'i (US)	4.6%
Sektör Ortalaması (Healthcare)	1.7%
Analist tahmini (COSM) (3 yıla kadar)	n/a

Önemli Temettü: COSM şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, COSM şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: COSM şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: COSM herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Cosmos Health Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

Cosmos Health Inc., Annual General Meeting, Nov 19, 2024

Cosmos Health Inc. Provides Earnings Guidance for the Year 2024, 2025, 2026, 2027

Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements

Positive Sentiment Still Eludes Cosmos Health Inc. (NASDAQ:COSM) Following 26% Share Price Slump

Cosmos Health Inc. announced delayed 10-Q filing

Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of its Forms 10-K and 10-Q

Cosmos Health Inc. announced delayed 10-Q filing

Cosmos Health Inc. announced delayed annual 10-K filing

Cosmos Health Inc. Receives Non-Compliance Letter from Nasdaq Related to Minimum Bid Price

Cosmos Health Inc. Commences Development of Cloudscreen 2.0 the New Iteration of Its Next Generation AI Drug Repurposing Platform

Cosmos Health Inc. Receives Regulatory Approval to Sell Sky Premium Life Products in UAE Nutritional Supplements Market

New major risk - Financial position

Cosmos Health Inc. has filed a Follow-on Equity Offering in the amount of $5.049535 million.

Slammed 27% Cosmos Health Inc. (NASDAQ:COSM) Screens Well Here But There Might Be A Catch

High number of new and inexperienced directors

Cosmos Health Inc. (NasdaqCM:COSM) completed the acquisition of Cloudscreen.

Cosmos Health Inc. announced delayed 10-Q filing

High number of new and inexperienced directors

Cosmos Health Inc. (NasdaqCM:COSM) signed an agreement to acquire Cloudscreen.

Cosmos Health Inc. Announces Executive and Board Changes

Cosmos Health Inc. Provides Earnings Guidance for the Year 2023

Cosmos Health Inc., Annual General Meeting, Sep 18, 2023

Cosmos Health Inc. announced delayed 10-Q filing

Second quarter 2023 earnings released: US$0.091 loss per share (vs US$23.37 loss in 2Q 2022)

Cosmos Health Inc. announced that it has received $5.25 million in funding

Cosmos Holdings Inc. (NasdaqCM:COSM) acquired 100% stakes in Cana Laboratories S.A. for approximately $1.67 million.

Cosmos Health Inc. Launches Terra Creta

Cosmos Health Inc. entered into letter of intent agreement to acquire Docpharm Arzneimittelvertrieb Gmbh & Co. Kg Auf Aktien.

Cosmos Health Inc. announced delayed 10-Q filing

Full year 2022 earnings released: US$33.16 loss per share (vs US$23.74 loss in FY 2021)

Cosmos Health Inc. Appoints Nikos Bardakis as Chief Operating Officer

Cosmos Health Inc. (NasdaqCM:COSM) announces an Equity Buyback for $3 million worth of its shares.

Cosmos Health Inc. announced that it has received $32.52568 million in funding

Cosmos Health Inc. announced that it has received $32.52568 million in funding

Cosmos Health Inc. has completed a Follow-on Equity Offering in the amount of $32.52568 million.

Cosmos Health Inc. has completed a Follow-on Equity Offering in the amount of $32.52568 million.

Chairman & CEO exercised options to buy US$605k worth of stock.

Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management

Third quarter 2022 earnings released: US$0.077 loss per share (vs US$0.11 loss in 3Q 2021)

Cosmos Holdings Inc., Annual General Meeting, Dec 02, 2022

Cosmos Holdings Inc. has completed a Follow-on Equity Offering in the amount of $7.5 million.

Cosmos Holdings Inc. (NasdaqCM:COSM) entered into a non-binding letter of intent agreement to acquire ZipDoctor, Inc from American International Holdings Corp. (OTCPK:AMIH).

Cosmos Holdings intends to acquire telemedicine platform ZipDoctor

Cosmos Holdings reports Q2 results

Cosmos Holdings Inc. announced delayed 10-Q filing

Cosmos Holdings Receives Non-Compliance Letter from Nasdaq Regarding Minimum Bid Price

Cosmos changes name to Cosmos Healthto

Cosmos Holdings Inc. (NasdaqCM:COSM) entered into a binding letter of intent to acquire Cana Laboratories S.A.

Cosmos climbs 11% on Cana Laboratories acquisition, expanding product line and integrating vertically

Cosmos Holdings, Inc. Appoints Dr. Panagiotis Zoumpoulakis to its Advisory Board

Cosmos Holdings Inc. (NasdaqCM:COSM) entered into an agreement to acquire product portfolio of Life NLB, Ltd.

Cosmos Holdings to acquire bone health product portfolio from LIFE NLB

Cosmos Holdings Inc. announced delayed 10-Q filing

Cosmos Holdings Inc. announced delayed annual 10-K filing

Cosmos Holdings Inc. announced delayed annual 10-K filing

Cosmos Holdings, Inc. Launches Osteodome in EU

Cosmos Holdings Inc. Launches New Proprietary Enhanced Dietary Supplement

Cosmos Holdings Inc. Appoints Georgios Terzis as Chief Financial Officer

Cosmos Holdings Inc. Announces David Lowenstein Agrees to Join Cosmos Board of Directors

Cosmos Holdings Inc. Announces Executive Changes

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin